Publication | Closed Access

Lower expression levels of the transforming growth factor beta receptor type II protein are associated with a less aggressive tumor phenotype and improved survival among patients with clear cell renal cell carcinoma

Tumor BiologyUrologyImproved SurvivalGenitourinary CancerAggressive Tumor PhenotypeMedicinePathologyLower Expression LevelsCancer BiologyCancer GrowthTumor MicroenvironmentCancer Research